Chemoinformaics analysis of 1,16-Hexadecanediol
| Molecular Weight | 258.446 | nRot | 15 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 0 |
| Exact Molecular Weight | 258.256 | nRing | 0 |
| Solubility: LogS | -4.271 | nHRing | 0 |
| Solubility: LogP | 4.93 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 50.995 |
| nHD | 2 | BPOL | 34.109 |
| QED | 0.427 |
| Synth | 1.295 |
| Natural Product Likeliness | 0.344 |
| NR-PPAR-gamma | 0.326 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.013 |
| HIA | 0.008 |
| CACO-2 | -4.8 |
| MDCK | 0.0000216 |
| BBB | 0.076 |
| PPB | 0.953926 |
| VDSS | 1.494 |
| FU | 0.022873 |
| CYP1A2-inh | 0.466 |
| CYP1A2-sub | 0.176 |
| CYP2c19-inh | 0.262 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.154 |
| CYP2c9-sub | 0.814 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.034 |
| CYP3a4-inh | 0.104 |
| CYP3a4-sub | 0.04 |
| CL | 7.163 |
| T12 | 0.308 |
| hERG | 0.183 |
| Ames | 0.006 |
| ROA | 0.023 |
| SkinSen | 0.955 |
| Carcinogencity | 0.065 |
| EI | 0.951 |
| Respiratory | 0.252 |
| NR-Aromatase | 0.352 |
| Antiviral | Yes |
| Prediction | 0.722596 |